CHESSA, Bernardo
 Distribuzione geografica
Continente #
NA - Nord America 3.943
AS - Asia 1.794
EU - Europa 1.416
SA - Sud America 1.082
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 66
OC - Oceania 6
Totale 8.380
Nazione #
US - Stati Uniti d'America 3.841
BR - Brasile 950
SG - Singapore 705
CN - Cina 513
IT - Italia 388
UA - Ucraina 333
DE - Germania 159
VN - Vietnam 138
HK - Hong Kong 126
SE - Svezia 106
FR - Francia 89
FI - Finlandia 79
GB - Regno Unito 64
BD - Bangladesh 62
IN - India 47
RU - Federazione Russa 39
AR - Argentina 36
TR - Turchia 33
CA - Canada 30
IQ - Iraq 29
MX - Messico 29
EC - Ecuador 23
BE - Belgio 21
CO - Colombia 21
ES - Italia 21
JP - Giappone 21
VE - Venezuela 21
ZA - Sudafrica 18
LT - Lituania 17
PL - Polonia 17
CZ - Repubblica Ceca 14
NL - Olanda 14
PK - Pakistan 14
PY - Paraguay 14
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 11
MA - Marocco 11
TN - Tunisia 10
KR - Corea 8
RO - Romania 8
AL - Albania 7
CH - Svizzera 7
ID - Indonesia 7
KE - Kenya 7
PE - Perù 7
AU - Australia 6
DZ - Algeria 6
IL - Israele 6
JO - Giordania 6
KG - Kirghizistan 6
NP - Nepal 6
PR - Porto Rico 6
SV - El Salvador 6
AZ - Azerbaigian 5
HN - Honduras 5
IR - Iran 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
BO - Bolivia 4
BY - Bielorussia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
EU - Europa 4
GP - Guadalupe 4
JM - Giamaica 4
KZ - Kazakistan 4
AM - Armenia 3
BH - Bahrain 3
BN - Brunei Darussalam 3
CL - Cile 3
GE - Georgia 3
GT - Guatemala 3
IE - Irlanda 3
MK - Macedonia 3
OM - Oman 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
EG - Egitto 2
GD - Grenada 2
GR - Grecia 2
HU - Ungheria 2
MY - Malesia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GH - Ghana 1
HR - Croazia 1
IM - Isola di Man 1
Totale 8.304
Città #
Dallas 940
Chandler 503
Singapore 358
San Jose 272
Ashburn 243
Jacksonville 196
Hong Kong 124
Beijing 122
Princeton 114
Council Bluffs 102
Santa Clara 100
Nanjing 91
Ann Arbor 78
Columbus 66
New York 65
Los Angeles 63
Dearborn 62
São Paulo 60
Lauterbourg 56
Wilmington 48
Ho Chi Minh City 45
Sassari 42
Hanoi 39
Rio de Janeiro 37
Boardman 32
Milan 31
Nanchang 31
Shanghai 31
Belo Horizonte 29
Woodbridge 28
Shenyang 24
Brussels 21
Helsinki 21
Changsha 20
Cagliari 19
Naples 19
San Francisco 19
Mountain View 18
Tokyo 18
Brooklyn 17
Campinas 17
Hebei 17
Tianjin 17
Brasília 16
Chennai 16
Munich 16
Baghdad 15
Orem 15
Curitiba 14
Porto Alegre 14
Rome 14
San Mateo 13
Andover 12
Atlanta 12
Guarulhos 12
Jiaxing 12
Johannesburg 12
Miano 12
Tashkent 12
Vilnius 12
Bogotá 11
Denver 11
Falkenstein 11
Kunming 11
Norwalk 11
Sorso 11
Toronto 11
Warsaw 11
Buffalo 10
Frankfurt am Main 10
Istanbul 10
Ningbo 10
Nuoro 10
Sumaré 10
Turin 10
Asunción 9
Mumbai 9
Salvador 9
Seattle 9
Augusta 8
Boston 8
Brno 8
Fortaleza 8
Goiânia 8
Jinan 8
London 8
Mexico City 8
Phoenix 8
Poplar 8
Quito 8
Santo André 8
Seoul 8
Sorocaba 8
Turku 8
Zhengzhou 8
Blumenau 7
Bologna 7
Campo Grande 7
Caracas 7
Chicago 7
Totale 4.841
Nome #
Development of a real-time PCR for detection of Mycoplasma agalactiae in bulk tank milk samples and epidemiology of infection in Sardinia 224
Anaplasma phagocytophilum, Sardinia, Italy 223
Caratterizazione antigenica della lipoproteina di membrana P48 di Mycoplasma bovis 200
Diagnosi molecolare di Anaplasma phagocytophilum e A. platys in cani e cavalli provenienti da aree della Sardegna ad alto tasso di “TICK-BORNE FEVER” ad eziologia sconosciuta 194
First report of canine leprosy in Europe: molecular and clinical traits 189
Caratterizzazione genetica e antigenica di una lipoproteina di superficie di Mycoplasma capricolum subsp. capricolum 182
Clonaggio, espressione e purificazione della proteina vp7 di bluetongue virus 180
Characterisation and Trasformant Properties of the New Ovine papillomavirus OVPV-3 177
Development and Clinical Trial of a Novel DNA Vaccine as Immunotherapy during Canine Leishmaniasis 176
Epidemiology and genetic characterization of Border Disease Virus circulating in Sardinia 175
Isolamento e caratterizzazione del genoma di un nuovo papillomavirus associato a carcinoma squamocellulare nella pecora sarda 175
A Paradigm for Virus–Host Coevolution: Sequential Counter-Adaptations between Endogenous and Exogenous Retroviruses 174
Clinical and Laboratory Findings in Equine Piroplasmosis 174
Caratterizazione molecolare ed antigenica di micoplasmi isolati da bovini in Sardegna 173
Characterisation of Mycoplasma capricolum P60 surface lipoprotein and its evaluation in a recombinant ELISA 173
Equus asinus Papillomavirus (EaPV1) provides new insights into equine papillomavirus diversity 170
Mycoplasma lipoproteins are major determinants of neutrophil extracellular trap formation 169
The liposoluble proteome of Mycoplasma agalactiae: an insight into the minimal protein complement of a bacterial membrane 163
Equine and canine Anaplasma phagocytophilum strains isolated on the island of Sardinia (Italy) are phylogenetically related to pathogenic strains from the United States 163
Comparison of different vitrification protocols on viability after transfer of ovine blastocysts in vitro produced and in vivo derived 163
Ovis aries Papillomavirus 3: a prototype of a novel genus in the family Papillomaviridae associated with ovine squamous cell carcinoma. 160
Distribution and genetic characterization of border disease virus circulating in Sardinian ovine flocks 158
Frazionamento dei subproteomi di micoplasmi agenti eziologici di agalassia contagiosa 156
A Paradigm for Virus–Host Coevolution: Sequential Counter Adaptations between Endogenous and Exogenous Retroviruses 156
Sintesi e valutazione delle proprietà immunomodulatorie di un lipopeptide diacilato derivato da Mycoplasma agalactiae 154
Genetic and antigenic characterization of the surface lipoprotein P48 of Mycoplasma bovis 152
Benefits of TEMPOL on ram semen motility and in vitro fertility: a preliminary study 151
Diagnosi molecolare di Anaplasma phagocytophilum e Anaplasma platys in cani e cavalli provenienti da aree della Sardegna ad alto tasso di “tick borne fever” ad eziologia sconosciuta 150
Detection and Characterization of Mycoplasma spp. and Salmonella spp. in Free-living European Tortoises (Testudo hermanni, Testudo graeca, and Testudo marginata) 147
Immunizzazione genetica di topi balbc con l’antigene p48 di Mycoplasma agalactiae 143
Sexing of in vitro produced ovine embryos by duplex PCR 140
Molecular investigation and phylogeny of anaplasma spp. in mediterranean ruminants reveal the presence of neutrophil-tropic strains closely related to A. platys 140
Mycoplasma agalactiae MAG_5040 is a Mg2+-Dependent, Sugar-Nonspecific SNase Recognised by the Host Humoral Response during Natural Infection 137
Un virus racconta la storia della pecora 133
Revealing the history of sheep domestication using retrovirus integrations 133
Molecular Cloning and Expression of a surface Lipoprotein of Mycoplasma Capricolum as a Potential Antigen for Serological Diagnosis 132
Development and clinical trial of a novel DNA vaccine as immunotherapy during canine Leishmaniasis 130
Molecular and antigenic characterization of a Mycoplasma bovis strain causing an outbreak of infectious keratoconjunctivitis 126
Effect of recombinant human FSH and LH on in vitro maturation of sheep oocytes; embryo development and viability 125
Identification of a novel Papillomavirus adapted to donkey skin: Equus asinus papillomavirus type 1 124
Allestimento di un vaccino a DNA controMycoplasma agalactiae 122
Mycoplasma Lipoproteins are Major Determinants of Neutrophil Extracellular Trap Formation 116
Studio e allestimento di un vaccino a dna contro M.agalactiae 116
Development of a Real-Time PCR for detection ofMycoplasma agalactiaein bulk tank milk samples and epidemiology of infection in Sardinia 114
The liposoluble proteome of M. agalactiae 111
Diagnosi molecolare di Anaplasma phagocytophilum e Anaplasma platys in cani e cavalli provenienti da aree della Sardegna ad alto tasso di “tick borne fever” ad eziologia sconosciuta. VII Congresso Nazionale S.I.Di.L.V. Torino, 26-28 Ottobre 2005 108
Identification and characterization of novel Mycoplasma spp. belonging to the hominis group from griffon vultures 107
Vitrification of metaphase II plate in sheep oocytes: preliminary study 104
Vitrification of sheep blastocysts: the choice of protocol does appear to affect the pregnancy and lambing rate 101
A Paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retroviruses 100
The Liposoluble proteome ofMycoplasma agalactiae: an insight into the minimal protein complement of a bacterial membrane 96
Epidemiology and genetic characterization of Border Disease Virus circulating in Sardinia 93
Sequential counter-adaptations between endogenous and exogenous retroviruses during evolution 90
Vitrification-survivol of blastocystsin improved by culture with albumin and Hyaluronan 89
Isolation, culture, and characterization of embryonic cell lines from vitrified sheep blastocysts 87
Identificazione, caratterizzazione genomica e filogenesi di un papillomavirus associato a carcinoma squamocellulare nella pecora sarda 87
Genetic immunization with the immunodominant antigen P48 of Mycoplasma agalactiae stimulates a mixed adaptive immune response in BALBc mice 86
Revealing the history of animal domestication and migrations using endogenous retroviruses 77
Mycoplasma agalactiaeMAG_5040 is a Mg2+-dependent, sugar-nonspecific SNase recognised by the host humoral response during natural infection 66
Mycoplasma agalactiaeMAG_5040 is a Mg2+-dependent, sugar-nonspecific SNase recognised by the host humoral response during natural infection 46
Totale 8.380
Categoria #
all - tutte 33.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022293 0 0 0 6 8 3 24 17 30 18 54 133
2022/2023878 65 89 19 160 76 137 0 107 138 15 45 27
2023/2024210 40 22 7 6 17 53 1 6 5 0 20 33
2024/20252.044 22 29 106 32 93 65 160 454 660 258 114 51
2025/20262.789 140 647 426 371 238 147 372 69 101 120 104 54
2026/2027734 56 179 205 294 0 0 0 0 0 0 0 0
Totale 8.380